PIK3CD and glioblastoma: To investigate the expression of different components of the PI3K/Akt signaling pathway in human glioma tissue, we performed IHC analysis on a glioma TMA, containing samples of 103 patients, ranging from WHO grade I (pilocytic astrocytoma) to WHO grade IV (GBM) (Figure 1A and Table S1).